Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin and Doxycycline for COVID-19 Recovery
NCT04523831Phase 3Completed
- Sponsor
- Dhaka Medical College
- Start
- Jun 2020
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ivermectin, doxycycline in coronavirus disease 2019 (COVID-19), sponsored by Dhaka Medical College. Started Jun 2020; status: completed.
02
Drugs
ivermectindoxycycline
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04523831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04523831.